Rhabdomyosarcomas in aging A/J mice

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Sher, Roger B ^a   Cox, Gregory A ^a   Mills, Kevin D ^a   Sundberg, John P ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DYSFERLIN; MYOGENIN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC REGULATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MOLECULAR GENETICS; MOUSE; MUSCLE REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROGRESSIVE MUSCULAR DYSTROPHY; RHABDOMYOSARCOMA; SARCOMERE; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; TRANSCRIPTOMICS; AGING; ANIMAL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE STRAIN; PATHOLOGY; SIGNAL TRANSDUCTION;

MAMMALIA; MUS;

AGING; ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED STRAINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION;

EID: 80051483012     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023498     Document Type: Article

References (47)

1. Wang Z, Velagaleti GV, Eltorky MA, Tang WW, Hawkins HK, et al. (2007) Cytogenetic and molecular studies of an unusual case of multiple primary alveolar rhabdomyosarcomas: low-level chromosomal instability and reciprocal translocation t(6;11). Exp Mol Pathol 82: 58-62.
2. Kramer S, Meadows AT, Jarrett P, Evans AE, (1983) Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst 70: 49-55.
3. Ognjanovic S, Linabery AM, Charbonneau B, Ross JA, (2009) Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer 115: 4218-4226.
4. Arndt CA, Crist WM, (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 342-352.
5. Hawkins WG, Hoos A, Antonescu CR, Urist MJ, Leung DH, et al. (2001) Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer 91: 794-803.
6. Huh MS, Smid JK, Rudnicki MA, (2005) Muscle function and dysfunction in health and disease. Birth Defects Res C Embryo Today 75: 180-192.
7. Stewart HL, Snell KC, Dunham LJ, Schlyen SM, (1959) Atlas of Tumor Pathology Section XII- Fascicle 40 Transplantable and Transmissible Tumors of Animals. In: Pathology AFIo, editors. Washington, D.C. Armed Forces Institute of Pathology pp. 83-91.
8. Sundberg JP, Adkison DL, Bedigian HG, (1991) Skeletal muscle rhabdomyosarcomas in inbred laboratory mice. Vet Pathol 28: 200-206.
9. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, et al. (1998) Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 4: 619-622.
10. Zibat A, Uhmann A, Nitzki F, Wijgerde M, Frommhold A, et al. (2009) Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts. Carcinogenesis 30: 918-926.
11. Yuan R, Tsaih SW, Petkova SB, Marin de Evsikova C, Xing S, et al. (2009) Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8: 277-287.
12. Sundberg JP, Berndt A, Sundberg BA, Silva KA, Kennedy V, et al. (2011) The mouse as a model for understanding chronic diseases of aging: the histopathology of aging inbred mice. Pathobiology of Aging & Age-related Diseases 1: 7179.
13. Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, et al. (2004) Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet 13: 1999-2010.
14. Fernandez K, Serinagaoglu Y, Hammond S, Martin LT, Martin PT, (2010) Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts. Am J Pathol 176: 416-434.
15. Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA, (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21: 2195-2204.
16. Ecke I, Petry F, Rosenberger A, Tauber S, Monkemeyer S, et al. (2009) Antitumor effects of a combined 5-aza-2′deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Cancer Res 69: 887-895.
17. Booth C, Sundberg JP, (1996) Spontanous neoplasms in a large breeding colony of BALB/cJ and BALB/cByJ mice. In: Mohr U, Dungworth DL, Capen CC, Carlton W, Sundberg JP, editors. Pathobiology of the Aging Mouse Washington, D.C. ILSI Press pp. 51-65.
18. Sundberg JP, Ichiki T, (2005) Common diseases found in inbred strains of laboratory mice. In: Sundberg JP, Ichiki T, editors. Handbook on genetically engineered mice Boca Raton CRC Press pp. 223-229.
19. Wanebo HJ, Gallmeier WM, Boyse EA, Old LJ, (1966) Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science 154: 901-903.
20. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, et al. (1999) Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 23: 141-142.
21. Petkov PM, Ding Y, Cassell MA, Zhang W, Wagner G, et al. (2004) An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 14: 1806-1811.
22. Nanni P, Nicoletti G, De Giovanni C, Croci S, Astolfi A, et al. (2003) Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Res 63: 2728-2732.
23. Brodie SG, Xu X, Li C, Kuo A, Leder P, et al. (2001) Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis. Oncogene 20: 1445-1454.
24. Li HG, Wang Q, Li HM, Kumar S, Parker C, et al. (2007) PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN. Cancer Lett 253: 215-223.
25. Fleischmann A, Jochum W, Eferl R, Witowsky J, Wagner EF, (2003) Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell 4: 477-482.
26. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, et al. (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 3: 113-117.
27. Keller C, Hansen MS, Coffin CM, Capecchi MR, (2004) Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. Genes Dev 18: 2608-2613.
28. Tsumura H, Yoshida T, Saito H, Imanaka-Yoshida K, Suzuki N, (2006) Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice. Oncogene 25: 7673-7679.
29. Asakura A, Rudnicki MA, (2003) Rhabdomyosarcomagenesis-Novel pathway found. Cancer Cell 4: 421-422.
30. Xia SJ, Pressey JG, Barr FG, (2002) Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 1: 97-104.
31. Sabbioni S, Barbanti-Brodano G, Croce CM, Negrini M, (1997) GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Res 57: 4493-4497.
32. Mercado GE, Barr FG, (2007) Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances. Curr Mol Med 7: 47-61.
33. De Giovanni C, Landuzzi L, Nicoletti G, Lollini PL, Nanni P, (2009) Molecular and cellular biology of rhabdomyosarcoma. Future Oncol 5: 1449-1475.
34. Tapscott SJ, Thayer MJ, Weintraub H, (1993) Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259: 1450-1453.
35. Sharp R, Recio JA, Jhappan C, Otsuka T, Liu S, et al. (2002) Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat Med 8: 1276-1280.
36. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, et al. (2009) The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 119: 2366-2378.
37. Nanni P, Nicoletti G, Palladini A, Astolfi A, Rinella P, et al. (2009) Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. Mol Cancer Ther 8: 754-761.
38. Jahnke VE, Sabido O, Defour A, Castells J, Lefai E, et al. (2010) Evidence for mitochondrial respiratory deficiency in rat rhabdomyosarcoma cells. PLoS One 5: e8637.
39. Hettmer S, Wagers AJ, (2010) Muscling in: Uncovering the origins of rhabdomyosarcoma. Nat Med 16: 171-173.
40. Tiffin N, Williams RD, Shipley J, Pritchard-Jones K, (2003) PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br J Cancer 89: 327-332.
41. Conboy IM, Rando TA, (2002) The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 3: 397-409.
42. Ishibashi J, Perry RL, Asakura A, Rudnicki MA, (2005) MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions. J Cell Biol 171: 471-482.
43. Oustanina S, Hause G, Braun T, (2004) Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J 23: 3430-3439.
44. Maas SA, Donghia NM, Tompkins K, Foreman O, Mills KD, (2010) ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells. BMC Biol 8: 132.
45. De Bortoli M, Castellino RC, Skapura DG, Shen JJ, Su JM, et al. (2007) Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases. Eur J Cancer 43: 1308-1317.
46. Seymour R, Ichiki T, Mikaelian I, Boggess D, Silva KA, et al. (2004) Necropsy Methods. The Laboratory Mouse. London Academic Press pp. 495-516.
47. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M, (2000) Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 13: 988-993.